Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

BiPar Sciences

BiPar Sciences is a pharmacological company developing PARP inhibitors as cancer therapies.

Acquired by Sanofi Aventis on April 15, 2009

Website: https://www.biparsciences.com

Founded: January 01, 2002

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
NarcX	Pharmaceuticals & Biotechnology	Be Part of the Solution - NarcX is the only solution that destroys and dispo ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...

View more competitors»

Date	Round	Amount	Investors
Jan 12, 2009	Series C	$ 20,000,000	Vulcan Capital Canaan Partners PolyTechnos Venture Partners Asset Management Ventures (AMV) Domain Associates Quantum Technology Partners
Nov 15, 2007	Venture	Undisclosed amount	Sand Hill Angels
Feb 26, 2007	Series B	$ 35,000,000	PolyTechnos Venture Partners Domain Associates Quantum Technology Partners Vulcan Capital Canaan Partners Asset Management Ventures (AMV)

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Tom White	Founder	Unknown to Unknown